Innate Lymphoid Cell Activation and Sustained Depletion in Blood and Tissue of Children Infected with HIV from Birth Despite Antiretroviral Therapy.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
15 09 2020
Historique:
received: 05 08 2019
revised: 14 03 2020
accepted: 25 08 2020
entrez: 16 9 2020
pubmed: 17 9 2020
medline: 5 5 2021
Statut: ppublish

Résumé

Innate lymphoid cells (ILCs) are important for response to infection and for immune development in early life. HIV infection in adults depletes circulating ILCs, but the impact on children infected from birth remains unknown. We study vertically HIV-infected children from birth to adulthood and find severe and persistent depletion of all circulating ILCs that, unlike CD4

Identifiants

pubmed: 32937142
pii: S2211-1247(20)31142-6
doi: 10.1016/j.celrep.2020.108153
pmc: PMC7495043
pii:
doi:

Substances chimiques

Anti-Retroviral Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

108153

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI133673
Pays : United States
Organisme : Wellcome Trust
ID : 210662/Z/18/Z
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : U24 AI118672
Pays : United States
Organisme : Wellcome Trust
ID : 107752/Z/15/Z
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : R01 HL134539
Pays : United States
Organisme : Wellcome Trust
ID : WT104748MA
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : U19 AI089992
Pays : United States
Organisme : Wellcome Trust
ID : 202485/Z/16/Z
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : R01 AI138546
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL095791
Pays : United States

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests The authors declare no competing interests.

Références

Nat Immunol. 2013 Mar;14(3):221-9
pubmed: 23334791
Nat Med. 2008 Oct;14(10):1077-87
pubmed: 18806803
J Infect Dis. 2005 May 1;191(9):1451-9
pubmed: 15809903
J Infect Dis. 2012 Feb 15;205(4):548-56
pubmed: 22205102
J Biol Chem. 2004 Oct 15;279(42):43675-83
pubmed: 15308666
Nat Rev Immunol. 2015 Jul;15(7):415-28
pubmed: 26065585
J Immunol. 2014 Oct 1;193(7):3344-54
pubmed: 25172483
Science. 2016 Mar 18;351(6279):1296-302
pubmed: 26989247
J Infect Dis. 2019 Apr 16;219(9):1407-1417
pubmed: 30624717
Eur J Biochem. 1993 Jan 15;211(1-2):347-55
pubmed: 8425544
Nat Rev Immunol. 2016 Apr;16(4):259-71
pubmed: 26972723
J Virol. 2016 Sep 12;90(19):8621-33
pubmed: 27440897
Nat Commun. 2018 Sep 27;9(1):3967
pubmed: 30262807
Front Immunol. 2014 Jan 13;4:498
pubmed: 24454311
PLoS Med. 2013 Oct;10(10):e1001542
pubmed: 24204216
Nat Rev Immunol. 2012 Sep;12(9):636-48
pubmed: 22918466
Mucosal Immunol. 2012 Nov;5(6):670-80
pubmed: 22854709
J Allergy Clin Immunol. 2003 Nov;112(5):973-80
pubmed: 14610491
Science. 2015 Nov 20;350(6263):981-5
pubmed: 26472762
Mucosal Immunol. 2012 Nov;5(6):646-57
pubmed: 22643849
Sci Transl Med. 2016 Sep 28;8(358):358fs16
pubmed: 27683549
Nat Rev Immunol. 2013 Feb;13(2):145-9
pubmed: 23348417
Nat Immunol. 2016 Apr;17(4):451-60
pubmed: 26878113
Cell. 2018 Aug 23;174(5):1054-1066
pubmed: 30142344
Front Immunol. 2014 Aug 12;5:391
pubmed: 25161656
Cell. 2017 Mar 9;168(6):1086-1100.e10
pubmed: 28283063
Protein Cell. 2017 Apr;8(4):242-254
pubmed: 28108952
Sci Transl Med. 2016 Sep 28;8(358):358ra125
pubmed: 27683550
Hum Vaccin Immunother. 2012 Dec 1;8(12):1784-94
pubmed: 22906931
Genome Biol. 2014;15(12):550
pubmed: 25516281
Mol Biol Cell. 2007 May;18(5):1701-9
pubmed: 17332504
Immunol Rev. 2016 May;271(1):185-99
pubmed: 27088915
Immunity. 2012 Sep 21;37(3):426-40
pubmed: 22999948
Nat Med. 2009 Aug;15(8):955-9
pubmed: 19597505
Front Immunol. 2019 Jul 02;10:1497
pubmed: 31333650
Nat Immunol. 2016 Nov;17(11):1291-1299
pubmed: 27618553
Nat Immunol. 2013 Dec;14(12):1285-93
pubmed: 24162775
Science. 2012 Jun 8;336(6086):1321-5
pubmed: 22674331
Nat Commun. 2020 Apr 14;11(1):1767
pubmed: 32286302
Nat Immunol. 2019 Aug;20(8):980-991
pubmed: 31209406
Annu Rev Immunol. 2019 Apr 26;37:521-546
pubmed: 30726153
Mucosal Immunol. 2018 Jan;11(1):236-248
pubmed: 28513595
BMC Bioinformatics. 2011 Aug 04;12:323
pubmed: 21816040
Nat Med. 2017 Nov;23(11):1277-1286
pubmed: 29035370
J Mol Biol. 2017 Nov 24;429(23):3577-3586
pubmed: 28867535
Front Immunol. 2017 Apr 24;8:470
pubmed: 28484464
Cell. 2016 May 19;165(5):1134-1146
pubmed: 27156452
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Blood. 2014 Jul 31;124(5):812-21
pubmed: 24855210
Front Immunol. 2013 Jan 08;3:417
pubmed: 23316201
Immunity. 2016 Feb 16;44(2):391-405
pubmed: 26850658
FASEB J. 2015 Dec;29(12):5072-80
pubmed: 26283536
PLoS Pathog. 2017 May 15;13(5):e1006373
pubmed: 28505204
J Immunol. 2007 Sep 1;179(5):3362-70
pubmed: 17709553
Nucleic Acids Res. 2014 Jul;42(13):8297-309
pubmed: 24939901
Nature. 2018 May;557(7706):585-589
pubmed: 29769719
J Immunol. 2002 Oct 15;169(8):4230-6
pubmed: 12370353
Nat Immunol. 2020 Mar;21(3):274-286
pubmed: 32066947
J Clin Invest. 2015 Sep;125(9):3692-703
pubmed: 26301812
Curr Opin HIV AIDS. 2016 Mar;11(2):146-55
pubmed: 26679413
Cell. 2016 Aug 25;166(5):1231-1246.e13
pubmed: 27545347
Nature. 2014 Apr 3;508(7494):123-7
pubmed: 24670648
Sci Transl Med. 2016 Jul 27;8(349):349ra100
pubmed: 27464748
Front Immunol. 2017 Dec 13;8:1818
pubmed: 29326704
Int J Epidemiol. 2011 Apr;40(2):385-96
pubmed: 21247884
Immunity. 2013 Oct 17;39(4):633-45
pubmed: 24138880
Front Immunol. 2017 Dec 07;8:1742
pubmed: 29375541
Blood. 2010 Apr 15;115(15):3058-69
pubmed: 20008791
Blood. 2011 Sep 22;118(12):3321-30
pubmed: 21791421
J Virol. 1994 Jul;68(7):4650-5
pubmed: 8207839
Nature. 2019 Jun;570(7762):528-532
pubmed: 31168092
Front Immunol. 2012 Dec 31;3:399
pubmed: 23293640
PLoS Pathog. 2015 Jun 15;11(6):e1004954
pubmed: 26076345
Lancet. 2004 Oct 2-8;364(9441):1236-43
pubmed: 15464184

Auteurs

Alveera Singh (A)

Africa Health Research Institute (AHRI), Durban 4001, South Africa.

Samuel W Kazer (SW)

Institute for Medical Engineering and Science, Department of Chemistry, and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02139, USA; Ragon Institute of MGH, Harvard, and MIT, Cambridge, MA 02139.

Julia Roider (J)

Africa Health Research Institute (AHRI), Durban 4001, South Africa; Department of Paediatrics, Peter Medawar Building for Pathogen Research, South Parks Rd, Oxford OX1 3SY, UK; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban 4001, South Africa; Medizinische Klinik IV, Department of Infectious Diseases, Ludwig-Maximilians-University, Munich 80802, Germany.

Kami C Krista (KC)

Institute for Medical Engineering and Science, Department of Chemistry, and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02139, USA; Ragon Institute of MGH, Harvard, and MIT, Cambridge, MA 02139.

Jane Millar (J)

Department of Paediatrics, Peter Medawar Building for Pathogen Research, South Parks Rd, Oxford OX1 3SY, UK; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban 4001, South Africa.

Osaretin E Asowata (OE)

Africa Health Research Institute (AHRI), Durban 4001, South Africa.

Abigail Ngoepe (A)

Africa Health Research Institute (AHRI), Durban 4001, South Africa.

Duran Ramsuran (D)

Africa Health Research Institute (AHRI), Durban 4001, South Africa.

Rabiah Fardoos (R)

Africa Health Research Institute (AHRI), Durban 4001, South Africa; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen 2200N, Denmark.

Amanda Ardain (A)

Africa Health Research Institute (AHRI), Durban 4001, South Africa; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban 4001, South Africa.

Maximilian Muenchhoff (M)

Department of Paediatrics, Peter Medawar Building for Pathogen Research, South Parks Rd, Oxford OX1 3SY, UK; Max von Pettenkofer Institute, Virology, National Reference Center for Retroviruses, Faculty of Medicine, LMU München, Munich 81377, Germany; German Center for Infection Research (DZIF), partner site Munich 80333, Germany.

Warren Kuhn (W)

ENT Department General Justice Gizenga Mpanza Regional Hospital (Stanger Hospital), University of KwaZulu-Natal, Durban 4001, South Africa.

Farina Karim (F)

Africa Health Research Institute (AHRI), Durban 4001, South Africa.

Thumbi Ndung'u (T)

Africa Health Research Institute (AHRI), Durban 4001, South Africa; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban 4001, South Africa; University College London, Division of Infection and Immunity, London WC1E 6AE, UK; Max Planck Institute for Infection Biology, Berlin 10117, Germany.

Alex K Shalek (AK)

Institute for Medical Engineering and Science, Department of Chemistry, and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02139, USA; Ragon Institute of MGH, Harvard, and MIT, Cambridge, MA 02139.

Philip Goulder (P)

Africa Health Research Institute (AHRI), Durban 4001, South Africa; Department of Paediatrics, Peter Medawar Building for Pathogen Research, South Parks Rd, Oxford OX1 3SY, UK; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban 4001, South Africa.

Alasdair Leslie (A)

Africa Health Research Institute (AHRI), Durban 4001, South Africa; University College London, Division of Infection and Immunity, London WC1E 6AE, UK; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban 4001, South Africa.

Henrik N Kløverpris (HN)

Africa Health Research Institute (AHRI), Durban 4001, South Africa; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen 2200N, Denmark; University College London, Division of Infection and Immunity, London WC1E 6AE, UK; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban 4001, South Africa. Electronic address: henrik.kloverpris@ahri.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH